title: [Hepatitis B in pregnancy: clinical and prophylactic implications].
abstract: Hepatitis B virus (HBV) infections occur worldwide, with the endemicity of infection varying among geographical areas. Infections acquired by perinatal via commonly become persistent and can progress to chronic liver diseases, including cirrhosis and hepatocellular carcinoma. The possibility of vertical transmission of the VHB infection depend of the serological condition of the mother, women with AgsHB positive can infect 10 to 20% of her fetus while women with AgsHB more AgeHB positive can infect 80-90% of her products. Newborns of women with acute or chronic HBV infection must be immunized with vaccine and hepatitis B immune globulin at birth with the objective to reduce the risk of infection.
authors.affiliation: Departamento de Infectología e Inmunología, Instituto Nacional de Perinatología, México, D.F.
authors.forename: R
authors.initials: R
authors.lastname: Figueroa Damián
authors.forename: L
authors.initials: L
authors.lastname: Sánchez Fernández
authors.forename: E
authors.initials: E
authors.lastname: Benavides Covarrubias
mesh_terms: D005260:Female; D005315:Fetal Diseases / Q000209:etiology; D006509:Hepatitis B / Q000517:prevention & control / Q000635:transmission; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006801:Humans; D007114:Immunization; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D012307:Risk Factors
chemical_list: D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D007136:Immunoglobulins; C045213:hepatitis B hyperimmune globulin